These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16094770)

  • 1. Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment.
    Cogliano V; Grosse Y; Baan R; Straif K; Secretan B; El Ghissassi F;
    Lancet Oncol; 2005 Aug; 6(8):552-3. PubMed ID: 16094770
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
    Shapiro S
    Lancet Oncol; 2005 Oct; 6(10):736; author reply 737. PubMed ID: 16198976
    [No Abstract]   [Full Text] [Related]  

  • 3. Oestroprogestagens and severe acute pyelonephritis: a casual or causal association?
    Piccoli GB; Colla L; Mezza E; Burdese M; Cammarota T; Piccoli G
    Nephrol Dial Transplant; 2006 Aug; 21(8):2337. PubMed ID: 16868038
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
    Szarewski A
    Lancet Oncol; 2005 Oct; 6(10):736-7; author reply 737. PubMed ID: 16198977
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of hormonal therapy related thrombosis.
    Sandset PM
    Thromb Res; 2013 Jan; 131 Suppl 1():S4-7. PubMed ID: 23452740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current aspects of the oral hormonal contraception].
    Avramova V
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():49-59. PubMed ID: 19504710
    [No Abstract]   [Full Text] [Related]  

  • 8. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
    Shulman LP
    Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy and the risk of breast cancer.
    Cuzick J
    Eur J Cancer; 2008 Nov; 44(16):2344-9. PubMed ID: 18783940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reviews of hormone replacement therapy evidence support findings in recently halted trial.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Sep; 13(17):7-9. PubMed ID: 12572547
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 12. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer risk during hormone therapy: experimental versus clinical data.
    Ruan X; Seeger H; Mueck AO
    Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sex steroids on proliferation in normal mammary tissue.
    Söderqvist G
    Ann Med; 1998 Dec; 30(6):511-24. PubMed ID: 9920352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient information. Hormone replacement therapy: frequently asked questions.
    Cleve Clin J Med; 2002 Sep; 69(9):680-1. PubMed ID: 12222971
    [No Abstract]   [Full Text] [Related]  

  • 18. Risks of hormone replacement therapy.
    Grant EC; Price EH; Steel CM
    Lancet; 1999 Oct; 354(9186):1302-3. PubMed ID: 10520664
    [No Abstract]   [Full Text] [Related]  

  • 19. Progestogens and venous thromboembolism among postmenopausal women using hormone therapy.
    Canonico M; Plu-Bureau G; Scarabin PY
    Maturitas; 2011 Dec; 70(4):354-60. PubMed ID: 22024394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and hypertension.
    Felmeden DC; Lip GY
    Blood Press; 2000; 9(5):246-9. PubMed ID: 11193126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.